Global Active Pharmaceutical Ingredient API Market Research Report 2023(Status and Outlook)
Report Overview
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
The Global Active Pharmaceutical Ingredient API Market Size was estimated at USD 63210.00 million in 2022 and is projected to reach USD 98874.94 million by 2029, exhibiting a CAGR of 6.60% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Active Pharmaceutical Ingredient API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredient API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredient API market in any manner.
Global Active Pharmaceutical Ingredient API Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Market Segmentation (by Type)
Anti-Infective
Hormonal
Others
Market Segmentation (by Application)
PCB Etching
Metal Etching
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Active Pharmaceutical Ingredient API Market
Overview of the regional outlook of the Active Pharmaceutical Ingredient API Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Active Pharmaceutical Ingredient API
- 1.2 Key Market Segments
- 1.2.1 Active Pharmaceutical Ingredient API Segment by Type
- 1.2.2 Active Pharmaceutical Ingredient API Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Active Pharmaceutical Ingredient API Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Active Pharmaceutical Ingredient API Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Active Pharmaceutical Ingredient API Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Active Pharmaceutical Ingredient API Market Competitive Landscape
- 3.1 Global Active Pharmaceutical Ingredient API Sales by Manufacturers (2018-2023)
- 3.2 Global Active Pharmaceutical Ingredient API Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Active Pharmaceutical Ingredient API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Active Pharmaceutical Ingredient API Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Active Pharmaceutical Ingredient API Sales Sites, Area Served, Product Type
- 3.6 Active Pharmaceutical Ingredient API Market Competitive Situation and Trends
- 3.6.1 Active Pharmaceutical Ingredient API Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredient API Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Active Pharmaceutical Ingredient API Industry Chain Analysis
- 4.1 Active Pharmaceutical Ingredient API Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Active Pharmaceutical Ingredient API Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Active Pharmaceutical Ingredient API Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Active Pharmaceutical Ingredient API Sales Market Share by Type (2018-2023)
- 6.3 Global Active Pharmaceutical Ingredient API Market Size Market Share by Type (2018-2023)
- 6.4 Global Active Pharmaceutical Ingredient API Price by Type (2018-2023)
- 7 Active Pharmaceutical Ingredient API Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Active Pharmaceutical Ingredient API Market Sales by Application (2018-2023)
- 7.3 Global Active Pharmaceutical Ingredient API Market Size (M USD) by Application (2018-2023)
- 7.4 Global Active Pharmaceutical Ingredient API Sales Growth Rate by Application (2018-2023)
- 8 Active Pharmaceutical Ingredient API Market Segmentation by Region
- 8.1 Global Active Pharmaceutical Ingredient API Sales by Region
- 8.1.1 Global Active Pharmaceutical Ingredient API Sales by Region
- 8.1.2 Global Active Pharmaceutical Ingredient API Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Active Pharmaceutical Ingredient API Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Active Pharmaceutical Ingredient API Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Active Pharmaceutical Ingredient API Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Active Pharmaceutical Ingredient API Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Active Pharmaceutical Ingredient API Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Teva
- 9.1.1 Teva Active Pharmaceutical Ingredient API Basic Information
- 9.1.2 Teva Active Pharmaceutical Ingredient API Product Overview
- 9.1.3 Teva Active Pharmaceutical Ingredient API Product Market Performance
- 9.1.4 Teva Business Overview
- 9.1.5 Teva Active Pharmaceutical Ingredient API SWOT Analysis
- 9.1.6 Teva Recent Developments
- 9.2 Mylan
- 9.2.1 Mylan Active Pharmaceutical Ingredient API Basic Information
- 9.2.2 Mylan Active Pharmaceutical Ingredient API Product Overview
- 9.2.3 Mylan Active Pharmaceutical Ingredient API Product Market Performance
- 9.2.4 Mylan Business Overview
- 9.2.5 Mylan Active Pharmaceutical Ingredient API SWOT Analysis
- 9.2.6 Mylan Recent Developments
- 9.3 DSM
- 9.3.1 DSM Active Pharmaceutical Ingredient API Basic Information
- 9.3.2 DSM Active Pharmaceutical Ingredient API Product Overview
- 9.3.3 DSM Active Pharmaceutical Ingredient API Product Market Performance
- 9.3.4 DSM Business Overview
- 9.3.5 DSM Active Pharmaceutical Ingredient API SWOT Analysis
- 9.3.6 DSM Recent Developments
- 9.4 Aurobindo Pharma
- 9.4.1 Aurobindo Pharma Active Pharmaceutical Ingredient API Basic Information
- 9.4.2 Aurobindo Pharma Active Pharmaceutical Ingredient API Product Overview
- 9.4.3 Aurobindo Pharma Active Pharmaceutical Ingredient API Product Market Performance
- 9.4.4 Aurobindo Pharma Business Overview
- 9.4.5 Aurobindo Pharma Active Pharmaceutical Ingredient API SWOT Analysis
- 9.4.6 Aurobindo Pharma Recent Developments
- 9.5 Aspen
- 9.5.1 Aspen Active Pharmaceutical Ingredient API Basic Information
- 9.5.2 Aspen Active Pharmaceutical Ingredient API Product Overview
- 9.5.3 Aspen Active Pharmaceutical Ingredient API Product Market Performance
- 9.5.4 Aspen Business Overview
- 9.5.5 Aspen Active Pharmaceutical Ingredient API SWOT Analysis
- 9.5.6 Aspen Recent Developments
- 9.6 Novartis
- 9.6.1 Novartis Active Pharmaceutical Ingredient API Basic Information
- 9.6.2 Novartis Active Pharmaceutical Ingredient API Product Overview
- 9.6.3 Novartis Active Pharmaceutical Ingredient API Product Market Performance
- 9.6.4 Novartis Business Overview
- 9.6.5 Novartis Recent Developments
- 9.7 BASF
- 9.7.1 BASF Active Pharmaceutical Ingredient API Basic Information
- 9.7.2 BASF Active Pharmaceutical Ingredient API Product Overview
- 9.7.3 BASF Active Pharmaceutical Ingredient API Product Market Performance
- 9.7.4 BASF Business Overview
- 9.7.5 BASF Recent Developments
- 9.8 Pfizer
- 9.8.1 Pfizer Active Pharmaceutical Ingredient API Basic Information
- 9.8.2 Pfizer Active Pharmaceutical Ingredient API Product Overview
- 9.8.3 Pfizer Active Pharmaceutical Ingredient API Product Market Performance
- 9.8.4 Pfizer Business Overview
- 9.8.5 Pfizer Recent Developments
- 9.9 Huahai Pharmaceutical
- 9.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredient API Basic Information
- 9.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient API Product Overview
- 9.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient API Product Market Performance
- 9.9.4 Huahai Pharmaceutical Business Overview
- 9.9.5 Huahai Pharmaceutical Recent Developments
- 9.10 Hisun Pharmaceutical
- 9.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredient API Basic Information
- 9.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredient API Product Overview
- 9.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredient API Product Market Performance
- 9.10.4 Hisun Pharmaceutical Business Overview
- 9.10.5 Hisun Pharmaceutical Recent Developments
- 9.11 Sun Pharmaceutical Industries
- 9.11.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient API Basic Information
- 9.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient API Product Overview
- 9.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient API Product Market Performance
- 9.11.4 Sun Pharmaceutical Industries Business Overview
- 9.11.5 Sun Pharmaceutical Industries Recent Developments
- 9.12 Zhejiang Medicine
- 9.12.1 Zhejiang Medicine Active Pharmaceutical Ingredient API Basic Information
- 9.12.2 Zhejiang Medicine Active Pharmaceutical Ingredient API Product Overview
- 9.12.3 Zhejiang Medicine Active Pharmaceutical Ingredient API Product Market Performance
- 9.12.4 Zhejiang Medicine Business Overview
- 9.12.5 Zhejiang Medicine Recent Developments
- 9.13 Dr. Reddy’s Laboratories
- 9.13.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient API Basic Information
- 9.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient API Product Overview
- 9.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient API Product Market Performance
- 9.13.4 Dr. Reddy’s Laboratories Business Overview
- 9.13.5 Dr. Reddy’s Laboratories Recent Developments
- 9.14 Zhejiang NHU
- 9.14.1 Zhejiang NHU Active Pharmaceutical Ingredient API Basic Information
- 9.14.2 Zhejiang NHU Active Pharmaceutical Ingredient API Product Overview
- 9.14.3 Zhejiang NHU Active Pharmaceutical Ingredient API Product Market Performance
- 9.14.4 Zhejiang NHU Business Overview
- 9.14.5 Zhejiang NHU Recent Developments
- 9.15 Bayer
- 9.15.1 Bayer Active Pharmaceutical Ingredient API Basic Information
- 9.15.2 Bayer Active Pharmaceutical Ingredient API Product Overview
- 9.15.3 Bayer Active Pharmaceutical Ingredient API Product Market Performance
- 9.15.4 Bayer Business Overview
- 9.15.5 Bayer Recent Developments
- 9.16 NCPC
- 9.16.1 NCPC Active Pharmaceutical Ingredient API Basic Information
- 9.16.2 NCPC Active Pharmaceutical Ingredient API Product Overview
- 9.16.3 NCPC Active Pharmaceutical Ingredient API Product Market Performance
- 9.16.4 NCPC Business Overview
- 9.16.5 NCPC Recent Developments
- 9.17 AbbVie
- 9.17.1 AbbVie Active Pharmaceutical Ingredient API Basic Information
- 9.17.2 AbbVie Active Pharmaceutical Ingredient API Product Overview
- 9.17.3 AbbVie Active Pharmaceutical Ingredient API Product Market Performance
- 9.17.4 AbbVie Business Overview
- 9.17.5 AbbVie Recent Developments
- 9.18 Shandong Xinhua Pharmaceutical
- 9.18.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient API Basic Information
- 9.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient API Product Overview
- 9.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient API Product Market Performance
- 9.18.4 Shandong Xinhua Pharmaceutical Business Overview
- 9.18.5 Shandong Xinhua Pharmaceutical Recent Developments
- 9.19 Northeast Pharm
- 9.19.1 Northeast Pharm Active Pharmaceutical Ingredient API Basic Information
- 9.19.2 Northeast Pharm Active Pharmaceutical Ingredient API Product Overview
- 9.19.3 Northeast Pharm Active Pharmaceutical Ingredient API Product Market Performance
- 9.19.4 Northeast Pharm Business Overview
- 9.19.5 Northeast Pharm Recent Developments
- 9.20 Harbin Pharmaceutical
- 9.20.1 Harbin Pharmaceutical Active Pharmaceutical Ingredient API Basic Information
- 9.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredient API Product Overview
- 9.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredient API Product Market Performance
- 9.20.4 Harbin Pharmaceutical Business Overview
- 9.20.5 Harbin Pharmaceutical Recent Developments
- 9.21 LKPC
- 9.21.1 LKPC Active Pharmaceutical Ingredient API Basic Information
- 9.21.2 LKPC Active Pharmaceutical Ingredient API Product Overview
- 9.21.3 LKPC Active Pharmaceutical Ingredient API Product Market Performance
- 9.21.4 LKPC Business Overview
- 9.21.5 LKPC Recent Developments
- 10 Active Pharmaceutical Ingredient API Market Forecast by Region
- 10.1 Global Active Pharmaceutical Ingredient API Market Size Forecast
- 10.2 Global Active Pharmaceutical Ingredient API Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Active Pharmaceutical Ingredient API Market Size Forecast by Country
- 10.2.3 Asia Pacific Active Pharmaceutical Ingredient API Market Size Forecast by Region
- 10.2.4 South America Active Pharmaceutical Ingredient API Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Active Pharmaceutical Ingredient API by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Active Pharmaceutical Ingredient API Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Active Pharmaceutical Ingredient API by Type (2024-2029)
- 11.1.2 Global Active Pharmaceutical Ingredient API Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Active Pharmaceutical Ingredient API by Type (2024-2029)
- 11.2 Global Active Pharmaceutical Ingredient API Market Forecast by Application (2024-2029)
- 11.2.1 Global Active Pharmaceutical Ingredient API Sales (K MT) Forecast by Application
- 11.2.2 Global Active Pharmaceutical Ingredient API Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook